Immune-mediated hepatitis
|
disease |
|
Disease or Syndrome
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Dyslipoproteinemias
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Insulin Sensitivity
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Angina Pectoris
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Sign or Symptom
|
139
|
65
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Alzheimer Disease, Early Onset
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
174
|
96
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Autoimmune hepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
190
|
22
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Autoimmune Chronic Hepatitis
|
disease |
Digestive System Diseases; Immune System Diseases
|
Disease or Syndrome
|
213
|
23
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Atherosclerotic lesion
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
253
|
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Hypertriglyceridemia
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
340
|
169
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Experimental Organism Basal Cell Carcinoma
|
phenotype |
Neoplasms
|
Neoplastic Process
|
437
|
63
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Dyslipidemias
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
471
|
184
|
0.320 |
None |
1.000 |
2 |
|
2015 |
2018 |
Carcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
557
|
91
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Impaired glucose tolerance
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
596
|
81
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
620
|
64
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Metabolic Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
945
|
50
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Liver diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
1019
|
100
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Metabolic Syndrome X
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1125
|
591
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2019 |
Coronary Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1282
|
440
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2018 |
Heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1499
|
201
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Coronary heart disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1576
|
1178
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2018 |
Coronary Artery Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1708
|
1577
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2018 |
Cardiovascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
1756
|
711
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |